| fatty acid oxidation | GO:0019395 | 28 | 0.966 | |
| lipid catabolic process | GO:0016042 | 69 | 0.949 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.942 | |
| monocarboxylic acid catabolic process | GO:0072329 | 27 | 0.898 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.883 | |
| lipid oxidation | GO:0034440 | 29 | 0.859 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.850 | |
| organic acid catabolic process | GO:0016054 | 51 | 0.842 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.720 | |
| peroxisome organization | GO:0007031 | 7 | 0.678 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.666 | |
| fatty acid beta oxidation | GO:0006635 | 16 | 0.582 | |
| lipid modification | GO:0030258 | 65 | 0.574 | |
| amino acid betaine metabolic process | GO:0006577 | 7 | 0.562 | |
| fatty acid catabolic process | GO:0009062 | 25 | 0.468 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.458 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.322 | Human Rat |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.316 | Human |
| oxidation reduction process | GO:0055114 | 342 | 0.294 | |
| fatty acid alpha oxidation | GO:0001561 | 2 | 0.284 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.260 | |
| thioester metabolic process | GO:0035383 | 19 | 0.235 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.226 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.208 | Human |
| establishment of protein localization to peroxisome | GO:0072663 | 4 | 0.187 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.183 | Human |
| protein targeting to peroxisome | GO:0006625 | 4 | 0.172 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.164 | |
| very long chain fatty acid metabolic process | GO:0000038 | 8 | 0.157 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.152 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.138 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.136 | |
| alpha amino acid biosynthetic process | GO:1901607 | 15 | 0.123 | |
| protein homooligomerization | GO:0051260 | 43 | 0.116 | |
| glutamine family amino acid biosynthetic process | GO:0009084 | 2 | 0.116 | |
| protein localization to peroxisome | GO:0072662 | 4 | 0.110 | |
| peroxisomal transport | GO:0043574 | 4 | 0.097 | |
| medium chain fatty acid metabolic process | GO:0051791 | 1 | 0.094 | |
| fatty acyl coa metabolic process | GO:0035337 | 4 | 0.089 | |
| pyrimidine containing compound catabolic process | GO:0072529 | 3 | 0.088 | |
| steroid metabolic process | GO:0008202 | 119 | 0.080 | Human Rat |
| cellular amine metabolic process | GO:0044106 | 44 | 0.076 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.073 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.073 | |
| amine metabolic process | GO:0009308 | 45 | 0.069 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.068 | |
| response to copper ion | GO:0046688 | 3 | 0.067 | |
| glycerophospholipid metabolic process | GO:0006650 | 71 | 0.062 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.061 | |
| intracellular protein transport | GO:0006886 | 204 | 0.060 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.059 | |
| male sex differentiation | GO:0046661 | 109 | 0.058 | |
| glutamate biosynthetic process | GO:0006537 | 2 | 0.057 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.057 | |
| dicarboxylic acid biosynthetic process | GO:0043650 | 5 | 0.056 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.055 | Human |
| lipid localization | GO:0010876 | 126 | 0.052 | Human |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.051 | |
| gonad development | GO:0008406 | 141 | 0.047 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.046 | |
| organic anion transport | GO:0015711 | 137 | 0.046 | Human |
| response to oxidative stress | GO:0006979 | 123 | 0.045 | |
| very long chain fatty acid catabolic process | GO:0042760 | 2 | 0.045 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.045 | |
| membrane organization | GO:0061024 | 245 | 0.043 | Human |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.041 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.040 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.040 | |
| hydrogen peroxide catabolic process | GO:0042744 | 5 | 0.039 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.039 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.039 | |
| protein import into peroxisome matrix | GO:0016558 | 3 | 0.039 | |
| isoprenoid metabolic process | GO:0006720 | 29 | 0.038 | |
| cofactor transport | GO:0051181 | 4 | 0.038 | |
| protein oligomerization | GO:0051259 | 67 | 0.038 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.038 | |
| branched chain amino acid catabolic process | GO:0009083 | 2 | 0.038 | |
| anion transport | GO:0006820 | 177 | 0.036 | Human |
| protein tetramerization | GO:0051262 | 23 | 0.035 | |
| male gamete generation | GO:0048232 | 285 | 0.035 | |
| response to inorganic substance | GO:0010035 | 96 | 0.034 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.034 | |
| maintenance of location | GO:0051235 | 89 | 0.033 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.033 | |
| spermatogenesis | GO:0007283 | 284 | 0.031 | |
| ossification | GO:0001503 | 216 | 0.031 | |
| pyruvate transport | GO:0006848 | 2 | 0.030 | |
| protein targeting | GO:0006605 | 143 | 0.030 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.030 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.030 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.029 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.029 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.028 | Human |
| response to nutrient levels | GO:0031667 | 109 | 0.028 | |
| spermatid differentiation | GO:0048515 | 115 | 0.028 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.027 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.027 | |
| protein localization to membrane | GO:0072657 | 108 | 0.027 | Human |
| leukocyte differentiation | GO:0002521 | 342 | 0.026 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.026 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.026 | |
| liver development | GO:0001889 | 66 | 0.025 | |
| androgen metabolic process | GO:0008209 | 11 | 0.025 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.025 | |
| response to transition metal nanoparticle | GO:1990267 | 11 | 0.024 | |
| cellular amino acid biosynthetic process | GO:0008652 | 22 | 0.024 | |
| plasma membrane organization | GO:0007009 | 90 | 0.023 | Human |
| macromolecule catabolic process | GO:0009057 | 281 | 0.023 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.023 | |
| cellular biogenic amine metabolic process | GO:0006576 | 28 | 0.023 | |
| epithelial cell development | GO:0002064 | 159 | 0.023 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.023 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.022 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.022 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.022 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.022 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.022 | |
| male gonad development | GO:0008584 | 88 | 0.022 | |
| cellular amino acid catabolic process | GO:0009063 | 25 | 0.022 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.021 | Human Rat |
| heart morphogenesis | GO:0003007 | 178 | 0.021 | |
| mapk cascade | GO:0000165 | 281 | 0.021 | |
| microtubule based process | GO:0007017 | 236 | 0.021 | |
| acyl coa metabolic process | GO:0006637 | 19 | 0.021 | |
| lipoprotein catabolic process | GO:0042159 | 7 | 0.021 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.021 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.020 | |
| regulation of protein localization | GO:0032880 | 231 | 0.020 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.020 | |
| innate immune response | GO:0045087 | 157 | 0.020 | |
| response to light stimulus | GO:0009416 | 135 | 0.020 | |
| pyrimidine nucleobase metabolic process | GO:0006206 | 3 | 0.020 | |
| nuclear transport | GO:0051169 | 139 | 0.020 | |
| defense response to other organism | GO:0098542 | 197 | 0.020 | |
| response to starvation | GO:0042594 | 65 | 0.020 | |
| lipoprotein metabolic process | GO:0042157 | 43 | 0.019 | |
| glucose metabolic process | GO:0006006 | 92 | 0.019 | |
| glycerophospholipid biosynthetic process | GO:0046474 | 32 | 0.019 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.019 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.019 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.019 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.019 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.018 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.018 | |
| regulation of toll like receptor 4 signaling pathway | GO:0034143 | 4 | 0.018 | |
| endomembrane system organization | GO:0010256 | 147 | 0.018 | Human |
| coenzyme biosynthetic process | GO:0009108 | 23 | 0.018 | |
| gland development | GO:0048732 | 330 | 0.018 | |
| immune effector process | GO:0002252 | 321 | 0.018 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.018 | Human |
| cellular homeostasis | GO:0019725 | 240 | 0.018 | |
| protein catabolic process | GO:0030163 | 221 | 0.018 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.018 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.017 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.017 | |
| regulation of protein stability | GO:0031647 | 52 | 0.017 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.017 | |
| phosphatidylcholine metabolic process | GO:0046470 | 13 | 0.017 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.017 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.017 | |
| phospholipid biosynthetic process | GO:0008654 | 36 | 0.017 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.017 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.016 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.016 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.016 | |
| alcohol biosynthetic process | GO:0046165 | 43 | 0.016 | Human |
| lipid transport | GO:0006869 | 98 | 0.016 | Human |
| protein localization to organelle | GO:0033365 | 185 | 0.016 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.016 | |
| lipid storage | GO:0019915 | 36 | 0.016 | |
| cargo loading into vesicle | GO:0035459 | 3 | 0.015 | |
| inositol lipid mediated signaling | GO:0048017 | 41 | 0.015 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.015 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.015 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.015 | |
| sensory perception | GO:0007600 | 245 | 0.015 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.015 | Human |
| protein maturation | GO:0051604 | 176 | 0.015 | |
| golgi vesicle transport | GO:0048193 | 30 | 0.015 | |
| sterol homeostasis | GO:0055092 | 45 | 0.014 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.014 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.014 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.014 | |
| forebrain development | GO:0030900 | 302 | 0.014 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.014 | |
| protein import | GO:0017038 | 101 | 0.014 | |
| female gonad development | GO:0008585 | 71 | 0.014 | |
| hexose metabolic process | GO:0019318 | 98 | 0.014 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.014 | |
| regulation of protein transport | GO:0051223 | 163 | 0.014 | |
| cytokine production | GO:0001816 | 319 | 0.014 | |
| macromolecule deacylation | GO:0098732 | 37 | 0.014 | |
| regulation of er to golgi vesicle mediated transport | GO:0060628 | 4 | 0.014 | |
| adiponectin activated signaling pathway | GO:0033211 | 4 | 0.014 | |
| lipid homeostasis | GO:0055088 | 63 | 0.014 | |
| regulation of fatty acid beta oxidation | GO:0031998 | 1 | 0.014 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.014 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.014 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.014 | |
| activation of immune response | GO:0002253 | 138 | 0.013 | |
| dna metabolic process | GO:0006259 | 303 | 0.013 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.013 | |
| axonogenesis | GO:0007409 | 274 | 0.013 | |
| fatty acid transmembrane transport | GO:1902001 | 1 | 0.013 | |
| negative regulation of intracellular transport | GO:0032387 | 38 | 0.013 | |
| organic acid transport | GO:0015849 | 101 | 0.013 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.013 | |
| regulation of defense response | GO:0031347 | 233 | 0.013 | |
| response to radiation | GO:0009314 | 165 | 0.013 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.013 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.013 | |
| glycogen biosynthetic process | GO:0005978 | 14 | 0.013 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.013 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.013 | |
| chromatin organization | GO:0006325 | 206 | 0.013 | |
| amide transport | GO:0042886 | 138 | 0.013 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.013 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.013 | |
| chromatin modification | GO:0016568 | 187 | 0.013 | |
| glutamate metabolic process | GO:0006536 | 9 | 0.012 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.012 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.012 | |
| response to steroid hormone | GO:0048545 | 56 | 0.012 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.012 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.012 | Human |
| response to organonitrogen compound | GO:0010243 | 246 | 0.012 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.012 | |
| hexose biosynthetic process | GO:0019319 | 39 | 0.012 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.012 | |
| valine metabolic process | GO:0006573 | 4 | 0.012 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.012 | |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.012 | Human |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.012 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.012 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.012 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.012 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.012 | |
| hydrogen peroxide metabolic process | GO:0042743 | 16 | 0.012 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.012 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.012 | |
| tricarboxylic acid metabolic process | GO:0072350 | 5 | 0.012 | |
| monosaccharide biosynthetic process | GO:0046364 | 44 | 0.011 | |
| skin development | GO:0043588 | 220 | 0.011 | |
| hemoglobin metabolic process | GO:0020027 | 13 | 0.011 | |
| telencephalon development | GO:0021537 | 186 | 0.011 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.011 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.011 | |
| exocytosis | GO:0006887 | 121 | 0.011 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.011 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.011 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.011 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.011 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.011 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.011 | |
| fat cell differentiation | GO:0045444 | 160 | 0.011 | |
| nuclear division | GO:0000280 | 158 | 0.011 | |
| selenium compound metabolic process | GO:0001887 | 3 | 0.011 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.011 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.011 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.011 | |
| hair follicle development | GO:0001942 | 85 | 0.011 | |
| germ cell development | GO:0007281 | 185 | 0.011 | |
| response to acid chemical | GO:0001101 | 111 | 0.011 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.011 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.011 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.011 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.011 | |
| negative regulation of nf kappab transcription factor activity | GO:0032088 | 15 | 0.011 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.011 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.010 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.010 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.010 | |
| membrane fusion | GO:0061025 | 38 | 0.010 | |
| rhythmic process | GO:0048511 | 174 | 0.010 | |
| hair cycle | GO:0042633 | 90 | 0.010 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.010 | |
| palate development | GO:0060021 | 76 | 0.010 | |
| response to drug | GO:0042493 | 75 | 0.010 | |
| cellular response to gamma radiation | GO:0071480 | 4 | 0.010 | |
